lenvatinib has been researched along with Hypoglycemia* in 2 studies
2 other study(ies) available for lenvatinib and Hypoglycemia
| Article | Year |
|---|---|
Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II.
A 77-year-old man was treated with a DPP-4 inhibitor for type 2 diabetes. Hypoglycemia occurred frequently, and an examination revealed a tumor with a maximum diameter of 140 mm in both lobes of the liver. Western immunoblotting detected a high-molecular-weight form of insulin-like growth factor-II, and non-islet cell tumor hypoglycemia was diagnosed. Although prednisolone 40 mg was started, hypoglycemia continued to occur frequently. Surgical tumor removal was not indicated, so lenvatinib was initiated. Hypoglycemia improved quickly, and the tumor shrank until it had partially disappeared. His condition continued to improve, and he was discharged. Topics: Aged; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Insulin-Like Growth Factor II; Liver Neoplasms; Male; Phenylurea Compounds; Quinolines | 2021 |
Lenvatinib in severe hypoglycemia associated with hepatocellular carcinoma.
We present the case of a 24-year-old male with multicentric hepatocellular carcinoma (HCC) over HBV-related compensated liver cirrhosis, on treatment with sorafenib and tenofovir. He had multiple admissions in recent months for severe hypoglycemia episodes with neurological symptoms. Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Hypoglycemia; Liver Neoplasms; Male; Phenylurea Compounds; Quinolines; Young Adult | 2021 |